Christof Iking‐Konert

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis

Claudia Metzler, N. Miehle, Karin Manger et al. · Lara D. Veeken · 2007 · 220 citations

Polymorphonuclear neutrophils as accessory cells for T‐cell activation: major histocompatibility complex class II restricted antigen‐dependent induction of T‐cell proliferation

Markus P. Radsak, Christof Iking‐Konert, Sabine Stegmaier et al. · Immunology · 2000 · 206 citations · Full text

Vacuolating Cytotoxin of <i>Helicobacter pylori</i> Induces Apoptosis in the Human Gastric Epithelial Cell Line AGS

Dirk Kuck, Bernhard Kolmerer, Christof Iking‐Konert et al. · Infection and Immunity · 2001 · 175 citations · Full text

Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)

Gerd R Burmester, Eugen Feist, H. Kellner et al. · Annals of the Rheumatic Diseases · 2010 · 161 citations · Full text

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial

Gerd R Burmester, Frank Buttgereit, Corrado Bernasconi et al. · The Lancet · 2020 · 121 citations · Full text

Rheumatoid Disorder, Rheumatology, Low Disease Activity +8